Topic Listing for Iomai

Accounts Receivable Additional Indications
Administration Eligibility Agreement Purchase Sell Stock
Amendment 2005 Stock Incentive Plan Amendment Facility Lease
Annual Bonus Annual Incentive Bonus
Antibody Response Toxin After Vaccination Attendance Board Meetings
Audit Fees Audit-related Fees
Availability Periodic Sec Reports Award Government Contract
Base Salary Basic Diluted Net Income Loss Attributable Common Stockholders
Basic Diluted Net Loss Attributable Common Stockholders Per Because Not Expect Pay Dividends Foreseeable Future Rely
Beneficial Ownership Reporting Compliance Biopharmaceutical Limited Operating History Generated Revenue Product Sales
Business Exposes Potential Product Liability Claims Cash Equivalents
Cautionary Statement Regarding Forward-looking Statements Certain Relationships Related Transactions
Certificate Amendment Change Control Arrangements 2005 Incentive Plan
Changes Internal Controls Over Financial Reporting Chief Executive Officer
Chief Executive Officer Compensation Closing
Code Business Conduct Ethics Commitment Good Corporate Governance
Committees Board Communications Board
Comparison 2004 2003 Comparison 2005 2004
Comparison 2006 2005 Comparison Cumulative Total Return Iomai Corporation Nasdaq Stock
Compensation Chief Executive Officer Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Committee Report Executive
Compensation Components Compensation Objective
Compensation Other Executive Officers Competition
Competitors Superior Products Manufacturing Capability Marketing Expertise Complaint Procedures
Comprehensive Loss Concentration Credit Risk Fair Value Financial Instruments
Conclusion Conditions Obligations Closing
Conditions Purchasers Obligations Closing Consideration Director Nominees
Corporate Information Critical Accounting Policies Estimates
Deal Hazardous Materials Cause Injury Others Regulated Environmental Depend Key Personnel Loss Adversely Affect Operations Fail
Description Proposed Amendments Plan Determination 2006 Compensation
Director Attendance Annual Meetings Director Compensation
Director Compensation Policy Directors Management Exercise Significant Control Over
Disclosure Controls Procedures Documents Incorporated Reference
Duties Responsibilities Election Directors
Employee Stock Purchase Plan Employees
Employment Agreements Change Control Arrangements Enhanced Immune Responses Elderly After Patch Application
Entry Material Definitive Agreement Estimates
Exact Name Registrant Specified Charter Executive Officers Registrant
Executive Sessions Independent Directors Expect Stock Price Fluctuate Significantly Adversely Affect Holders
Experience Sales Marketing Distribution Depend Efforts Parties Facility Sublease
Federal Income Tax Consequences Relating 2005 Incentive Plan Financial Operations Review
Financial Statements Exhibits Financing History
Form 10-k Function
General Administrative Expense General Philosophy
Governance Guidelines Government Agencies Special Contracting Requirements Create Additional Risks
Government Regulation Grants Plan-based Awards
Historical Results Operations Liquidity Capital Resources History Operating Losses Never Profitable
Immune System Vaccines Immunostimulant Patch Elderly Receiving Flu Vaccines
Incentive Plan Income Taxes
Indemnification Officers Directors Independence Directors
Independent Directors Independent Registered Public Accounting Firm
Index Financial Statements Influenza
Influenza Elderly Initial Public Offering
Initial Target Markets Involved Lawsuits Protect Enforce Patents Collaborators Licensors Expensive
Iomai Corporation Iomai Corporation Securities Purchase Agreement
Key Responsibilities License Tci Technology Walter Reed Army Institute Research
Long-term Equity Incentives Management Oversight
Management Review 2006 Manufacturing Commercial Supply
Market Overview Marketable Securities
Membership Need Additional Funding Cannot Guarantee Find Adequate Sources
Needle-free Flu Vaccine Patch Needle-free Pandemic Flu Vaccine Patch
Needle-free Travelers Diarrhea Vaccine Patch New Plan Benefits
Nominees Class Directors Terms Expire 2010 Nominees Election Directors
Nonqualified Deferred Compensation Not Able Manufacture Product Candidates Commercial Quantities Prevent
Not Achieve Projected Development Goals Time Frames Announce Notice Annual Meeting Stockholders
Option Exercises Year-end Values Option Grants
Option Grants Exercises Options Exercised Stock Vested
Organization Organization Governance
Other Other Compensation
Other Events Other Executive Officers
Other Fees Other Matters
Overview Pandemic Flu
Part Part Product Development Efforts Make Significant Changes Candidates
Patch Elderly Receiving Flu Vaccines Patch Pandemic Flu
Patch Pandemic Flu Program Relies Government Health Organizations Performance Board
Physicians Patients Not Accept Products Unable Generate Significant Plan Distribution
Plans Funds Continue Clinical Development Novel Patch- Based Powers Compensation Committee
Powers Corporate Governance Committee Preferred Stock
Price Volume Common Stock Experience Extreme Fluctuations Then Private Placement
Private Placement Public Equity Product Candidates Been Approved Commercial Sale Never Receive
Products Approved Commercial Sale Subject Penalties Fail Comply Products Development
Property Equipment Provisions Delaware Law Charter Documents Delay Prevent Acquisition
Proxy Statement Purpose
Recent Accounting Pronouncements Recently Began Developing Manufacturing Heat Labile Toxin Not
Recently Began Testing New Formulation Tci Patch Technology Recitals
Related Party Transaction Policies Procedures Related Party Transactions
Rely Parties Conduct Clinical Trials Those Third-parties Not Report Audit Committee
Report Independent Registered Public Accounting Firm Representations Warranties Certain Agreements Purchasers
Required Conduct Clinical Trials Patch Flu Vaccines Developed Research Development Costs
Research Development Expenses Restricted Cash Marketable Securities
Results Operations Revenue Recognition
Revenues Role Board Directors
Rule 14a-101 Sale Series Preferred Stock Elan
Sales Marketing Schedule Purchasers
Securities Authorized Issuance Equity Compensation Plans Separate Copies Beneficial Holders
Series Convertible Preferred Stock Series Convertible Redeemable Preferred Stock
Series Preferred Stock Warrants Signature Page Securities Purchase Agreement Dated 2006 Among
Signatures Skin Preparation Systems Used Connection Product Candidates Make
Skin Pretreatment Methods Used Connection Product Candidates Make Special Meeting Stockholders
Statement Purpose Stock Compensation
Stock Incentive Plan Stock Option Plan
Stock Options Stock Performance
Stock Performance Graph Stock Warrants
Stock-based Compensation Stockholder Communications Board
Stockholder Proposals Stockholder Proposals 2008 Annual Meeting
Strategy Summary Compensation Executive Officers
Summary Existing 2005 Incentive Plan Table Contents
Tax Fees Tci Solution
Technology Conflicts Intellectual Property Rights Parties Incur Substantial Technology Unproven Presents Challenges Product Development Efforts
Termination Based Compensation Travelers Diarrhea
Unable Protect Confidentiality Proprietary Information Know-how Value Technology Unable Protect Intellectual Property Not Able Operate Business
Unregistered Sales Equity Securities Vote Required
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki